Salt Composition
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Metastatic breast cancer
Customers also bought
More About Eribilin Injection
Benefits
In Metastatic breast cancer Eribilin Injection helps to treat breast cancer and it may be used alone or in combination with other medicines or treatment modalities like chemotherapy. This medicine is used when other medicines have not shown significant improvement and the cancer has spread to other parts as well. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Eribilin Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Your doctor or nurse will guide you how to use this medicine.
How it works
Eribilin Injection is an anticancer medication. It works by interfering with the microtubule structures which help the cancer cells to divide and multiply. This blocks the growth cycle (cell cycle) of cancer cells and eventually kills them.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Eribilin Injection . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Seek medical advice from your doctor: Eribilin Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Not Safe: Eribilin Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Not Safe: Eribilin Injection may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Caution Advised: Eribilin Injection should be used with caution in patients with kidney disease. Dose adjustment of Eribilin Injection may be needed. Doctor consultation is advised.
Caution Advised: Eribilin Injection should be used with caution in patients with liver disease. Dose adjustment of Eribilin Injection may be needed. Doctor consultation is advised.
Manufacturer Address
255/2, Hinjawadi, Pune - 411057, India
References
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 489
Central Drugs Standard Control Organisation (CDSCO) (27 Mar. 2019)
Eribulin Mesylate. Frankfurt am Main Germany: Eisai GmbH; 17 Mar. 2011 (27 Mar. 2019)
Cancer Research Uk. Eribulin Mesylate (27 Mar. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
